XTX Topco’s Adamas Pharmaceuticals ADMS Stock Holding History

XTX Topco’s Portfolio ADMS Stock Details ADMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-16,357	Closed	-$86K	–	1207
2021 Q2	$86K	Buy	+16,357	New	+$84.7K	0.03%	679

Other funds holding ADMS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CCPM

Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

XTX Topco's ADMS Position: Q3 2021 in Review

XTX Topco sold out of Adamas Pharmaceuticals (ADMS) in Q3 2021, closing a stake of 16,357 shares — an estimated $86K sold.

XTX Topco first reported a position in ADMS in Q2 2021 and held it in 1 quarter. The position peaked at $86K in Q2 2021. 63 funds tracked by Wall St. Rank hold ADMS as of Q3 2021.

XTX Topco reported no remaining Adamas Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
XTX Topco sold 16,357 Adamas Pharmaceuticals shares in Q3 2021, an estimated $86K.
XTX Topco first reported a position in Adamas Pharmaceuticals in Q2 2021 and held it in 1 quarter.
XTX Topco's Adamas Pharmaceuticals position peaked at $86K in Q2 2021.
63 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q3 2021.

Based on XTX Topco's 13F filing for Q3 2021, filed 12 Nov 2021.